Log In
Monday 24th October 2016

Genetic service launched

31st August 2006

Opaldia has launched a new service to offer a comprehensive genetics programme for breast and other cancers.

 It will offer genetic medicine services, including: genetic information, counselling and testing services; gene profiling initially for breast cancer and cancer of unknown primary (CUP); lifetime cancer surveillance programmes.

It will also provide the latest proven molecular diagnostic testing for cancer, plus research and development to help advance the field. The company is working under the medical guidance of leading oncologists, Karol Sikora, professor of cancer medicine at Imperial College School of Medicine, and Dr James Mackay, consultant clinical genetic oncologist with University College London. Clinics will be run initially at private hospitals and clinics in London, with further clinics to be rolled out across the UK.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016